Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Creams: SOP for Identifying Critical Process Parameters in Cream Manufacturing – V 2.0

Posted on By

Creams: SOP for Identifying Critical Process Parameters in Cream Manufacturing – V 2.0

Standard Operating Procedure for Identifying Critical Process Parameters in Cream Manufacturing

Department Creams
SOP No. SOP/CRM/038/2025
Supersedes SOP/CRM/038/2022
Page No. Page 1 of 5
Issue Date 03/09/2025
Effective Date 08/09/2025
Review Date 03/09/2026

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to outline the process for identifying and monitoring critical process parameters (CPPs) in cream manufacturing. Identifying CPPs is essential for ensuring product consistency, quality, and compliance with regulatory standards. This SOP provides guidance for evaluating and controlling these parameters during production.

2. Scope

This SOP applies to all cream formulations developed and produced within the Creams Department. It includes the identification, monitoring, and control of critical process parameters throughout the manufacturing process to ensure that the cream products meet the required quality standards.

3. Responsibilities

  • Formulation Development Team: Responsible for identifying potential critical process parameters during the formulation development phase and ensuring that the formulation design is robust enough to accommodate them.
  • Quality Control (QC): Responsible for monitoring the critical process parameters during production and conducting tests to ensure that they remain within the specified limits.
  • Quality Assurance (QA): Ensures compliance with this SOP, reviews the identified CPPs, and approves the final formulation and process controls for commercial production.
  • Production Team: Implements process control measures and ensures that the manufacturing process is carried out within the identified critical parameters for each batch of cream produced.

4. Accountability

The Head of Creams Manufacturing is responsible for overseeing the identification and control of critical process parameters in the cream manufacturing process. The QA Manager is accountable for ensuring that this SOP is followed, and that CPPs are properly identified, monitored, and documented.

See also  Creams: SOP for Cleaning Packaging Lines in Cream Manufacturing - V 2.0

5. Procedure

5.1 Identification of Critical Process Parameters

  1. Review the cream formulation and manufacturing process to identify the key variables that could affect the final product’s quality, performance, and stability. Critical process parameters typically include:

    • Temperature: The temperature at various stages of the manufacturing process (e.g., mixing, emulsification, cooling) can significantly affect the cream’s texture and stability.
    • Mixing Time and Speed: The duration and speed of mixing influence the cream’s consistency, homogeneity, and ability to maintain stability over time.
    • pH: pH levels affect the stability, efficacy, and sensory properties of the cream. It is essential to monitor pH during the manufacturing process.
    • Viscosity: The viscosity of the cream formulation is an important indicator of texture and spreadability. Monitoring viscosity during the mixing process ensures the desired product consistency.
    • Shear Rate: Shear forces during mixing can influence the cream’s emulsion stability and consistency.
  2. Document all identified critical process parameters in the Critical Process Parameter Log (Annexure-1), including their specific limits and the rationale for considering them as critical.

5.2 Setting Control Limits for CPPs

  1. For each critical process parameter identified, establish the acceptable range of variation (control limits) that will ensure the cream formulation meets the desired quality attributes. These limits should be based on:

    • Historical data from similar formulations
    • Pre-formulation studies
    • Regulatory requirements and industry standards
  2. Review and approve the control limits with the QA team to ensure they align with the desired product specifications.
  3. Control limits should be set for both upper and lower values, and should be regularly reviewed and adjusted based on production data.
See also  Creams: SOP for Start-Up and Shutdown of Manufacturing Equipment - V 2.0

5.3 Monitoring and Controlling CPPs during Production

  1. Monitor critical process parameters continuously or at specified intervals during the manufacturing process. Use automated systems or manual methods to record data on key parameters such as temperature, pH, viscosity, and mixing time.
  2. Compare the real-time data with the established control limits. If any critical process parameter falls outside the acceptable range, implement corrective actions immediately to bring the process back within specification. Common corrective actions may include:

    • Adjusting mixing speed or time
    • Correcting temperature deviations
    • Re-adjusting pH or viscosity as required
  3. Document any deviations and corrective actions taken, including the cause of the deviation, the corrective measure implemented, and the outcome.
  4. If a critical parameter cannot be corrected within an acceptable time frame, stop production and investigate further. Escalate the issue to the QA team for resolution.

5.4 Documentation and Reporting

  1. Maintain detailed records of all critical process parameters throughout the manufacturing process. The records should include:

    • Identification of each CPP
    • Control limits for each parameter
    • Real-time monitoring data
    • Any corrective actions taken during production
  2. Prepare a Critical Process Parameter Monitoring Report (Annexure-2) summarizing the monitoring data, deviations, and corrective actions. This report should be reviewed and approved by the QA team.

5.5 Review and Evaluation of CPPs

  1. Periodically review the effectiveness of the control limits and the monitoring of critical process parameters. Use production data, stability test results, and customer feedback to assess whether the parameters need to be updated or refined.
  2. Conduct regular process reviews with the Formulation Development Team, QC, and QA to ensure that the critical process parameters are still relevant and effective in maintaining the quality and stability of the cream product.
See also  Creams: SOP for Texture and Spreadability Testing of Creams - V 2.0

5.6 Final Approval and Commercial Production

  1. Once the critical process parameters are properly controlled and validated, the cream formulation is ready for commercial production. Ensure that these parameters are monitored continuously during the production of each batch.
  2. Store all data and documentation related to CPPs for regulatory compliance and future reference.

6. Abbreviations

  • QC: Quality Control
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practices
  • CPP: Critical Process Parameter
  • API: Active Pharmaceutical Ingredient

7. Documents

  1. Critical Process Parameter Log (Annexure-1)
  2. Critical Process Parameter Monitoring Report (Annexure-2)
  3. Batch Record (Annexure-3)

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • FDA Guidelines for Cosmetic Product Manufacturing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Critical Process Parameter Log

Critical Process Parameter Control Limits Monitoring Method Reason for Criticality
Temperature 65°C ± 2°C Thermometer/Temperature Sensor Affects emulsification and viscosity

Annexure-2: Critical Process Parameter Monitoring Report

Batch Number Parameter Real-Time Data Corrective Action Taken
12345 Temperature 66°C Adjusted mixing speed to reduce temperature

Annexure-3: Batch Record

Batch Number Process Parameter Recorded Value Action Taken
12345 pH 5.6 Adjusted pH to target 5.5

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: Capsule: SOP for Labeling Capsules with Lot Numbers – V 2.0
Next Post: Tablets: SOP for Automated In-Process Data Review Systems – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version